Efficacy and safety of a premixed versus a basal-plus insulin regimen as intensification for type 2 diabetes by timing of the main meal.

CONCLUSIONS: Glycaemic control improved in patients receiving either LM25 or IGL, irrespective of main meal timing. Both regimens can be used in patients with inadequate glycaemic control who are in need of insulin intensification. PMID: 26934128 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/26934128?dopt=Abstract

Source: Current Medical Research and Opinion - March 6, 2016 Category: Research Tags: Curr Med Res Opin Source Type: research